Cyclodextrin-Nanosponge-Loaded Cyclo-Oxygenase-2 Inhibitor-Based Topical Gel for Treatment of Psoriatic Arthritis: Formulation Design, Development, and <i>In vitro</i> Evaluations

<b>Background:</b> Psoriatic arthritis (PsA), a chronic inflammatory disease, mainly affects the joints, with approximately 30% of psoriasis patients eventually developing PsA. Characterized by both innate and adaptive immune responses, PsA poses significant challenges for effective treatment. Recen...

Description complète

Détails bibliographiques

Auteurs principaux:	Umme Hani, Sharanya Paramshetti, Mohit Angolkar, Wajan Khalid Alqathanin, Reema Saeed Alghaseb, Saja Mohammed Al Asmari, Alhanouf A. Alsaab, Farhat Fatima, Riyaz Ali M. Osmani, Ravi Gundawar
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-11-01
Collection:	Pharmaceuticals
Sujets:	cyclodextrin nanosponge solubility controlled release solubility enhancement psoriatic arthritis
Accès en ligne:	https://www.mdpi.com/1424-8247/17/12/1598
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!